Personalized prediction for a 69 year old man who takes Methylene Blue, Methylphenidate (an AI-powered real world drug study)

Summary:

This is a personalized prediction of potential side effects and undetected conditions for up to one year, if you would have adverse effects. The study is created by eHealthMe based on data from the FDA.

What are the drugs?

Methylene blue has active ingredients of methylene blue. eHealthMe is studying from 1,058 Methylene blue users. Check the latest studies of Methylene blue.
Methylphenidate has active ingredients of methylphenidate. eHealthMe is studying from 8,211 Methylphenidate users. Check the latest studies of Methylphenidate.

What are the conditions?

General health: no further information found.
Adhd (adhd-mental disorders that develop in children) is found to be associated with 607 drugs and 1,367 conditions by eHealthMe. Check the latest studies of Adhd.

Potential side effects:

Death

5.27% for males aged 69 (±5) who take methylene blue
5.27% for males aged 69 (±5) who take methylphenidate

Depression

6.35% for males aged 69 (±5) who have general health and adhd

Dizziness

8.25% for males aged 69 (±5) who have general health and adhd

Drowsiness

6.35% for males aged 69 (±5) who have general health and adhd

Drug ineffective

17.78% for males aged 69 (±5) who have general health and adhd

Fatigue

12.7% for males aged 69 (±5) who have general health and adhd

Feeling abnormal

6.98% for males aged 69 (±5) who have general health and adhd

Insomnia

9.84% for males aged 69 (±5) who have general health and adhd

Memory loss

7.3% for males aged 69 (±5) who have general health and adhd

Stress and anxiety

7.62% for males aged 69 (±5) who have general health and adhd

Urination - painful

5.4% for males aged 69 (±5) who have general health and adhd

Weakness

6.03% for males aged 69 (±5) who have general health and adhd

Potential co-existing conditions:

Attention deficit hyperactivity disorder

100.0% for males aged 69 (±5) who have general health and adhd

Depression

16.19% for males aged 69 (±5) who have general health and adhd

Gastroesophageal reflux disease

7.94% for males aged 69 (±5) who have general health and adhd

High blood cholesterol

9.52% for males aged 69 (±5) who have general health and adhd

High blood pressure

13.33% for males aged 69 (±5) who have general health and adhd
5.69% for males aged 69 (±5) who take methylene blue
5.69% for males aged 69 (±5) who take methylphenidate

Multiple myeloma

5.36% for males aged 69 (±5) who take methylene blue
5.36% for males aged 69 (±5) who take methylphenidate

Pain

9.84% for males aged 69 (±5) who have general health and adhd

Stress and anxiety

9.21% for males aged 69 (±5) who have general health and adhd

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used, and more. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

Related publications that referenced our studies

Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.